Kherani S, et al. - In this retrospective case series, experts assessed the factors influencing the visual outcome in subjects with neovascular age-related macular degeneration (NVAMD) and subfoveal hemorrhage (SFH) treated with anti-vascular endothelial growth factor (VEGF) agents. Individuals with NVAMD and thick SFH, but a short distance between fovea and uninvolved retina could have good visual outcomes after frequent anti-VEGF injections. Hence, it was inferred that the smaller area of SFH at baseline and high frequency of anti-VEGF injections were the 2 independent variables that correlated with good visual outcome.